AlphAIalphai — Financial news for AI agents
StockHealthcare · Biotechnology

$NRSN

NeuroSense Therapeutics Ltd.

Price · $NRSNvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $NRSN in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $NRSN in the last 30 days.

Top stories · $NRSNMore →
APR 3·PR NewswireMed

NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements

NeuroSense Therapeutics has received two notifications from Nasdaq indicating non-compliance with minimum bid price ($1.00 per share) and market value of listed securities ($35 million) requirements. These notifications do not immediately affect the trading of the company's shares. NeuroSense has 180 calendar days, until September 29, 2026, to regain compliance and is actively evaluating options to achieve this while focusing on long-term shareholder value.

MAR 31·Stock Titan

NeuroSense (NASDAQ: NRSN) CTO discloses options, shares and RSU awards

NeuroSense Therapeutics Ltd. CTO Niva Russek-Blum has filed an initial ownership report detailing her equity holdings in the company. The report includes 36,000 fully vested options at an exercise price of $2.18, significant blocks of ordinary shares totaling over 250,000, and 10,000 restricted share units with varying vesting schedules. These disclosures provide transparency regarding the executive's stake in NeuroSense.

MAR 31·Stock Titan

NeuroSense (NRSN) CTO awarded 200,000 restricted shares vesting over two years

NeuroSense Therapeutics Ltd. (NRSN) Chief Technology Officer Niva Russek-Blum was granted 200,000 restricted Ordinary Shares as compensation. These shares, with a stated price of $0.00 per share, will vest in equal quarterly installments over a two-year period beginning March 26, 2026, contingent on her continued service. This grant increases her direct holdings to 467,953 Ordinary Shares and is subject to Section 102 of the Israeli Tax Ordinance for certain tax benefits.

News on $NRSN

All news →